- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05629156
Injury and Illness Surveillance at the FIFA World Cup Qatar 2022TM (IISFWC22)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background Injury rates in football are closely associated with team performance. Teams are more likely to lose matches in which they have suffered injuries, and teams with fewer injuries have significantly better results both in international tournaments and in national leagues. Injuries can have both high short- and long-term consequences for an individual player's health and career. Illness rates in professional football is lower than injury rates, but it is unclear whether illness rates are higher in international tournaments, which often include travel, exposure to different environments, high match significance, and match congestion.
Injury surveillance is a cornerstone in the development of injury prevention programs. Injury and illness prevention strategies are continuously being developed and improved, and it is therefore important with ongoing surveillance. Additionally, there has been scientific advances in methodology, which can ensure more detailed and accurate information.
Objectives The primary objective is to provide an overview of the incidence and characteristics of time-loss injuries and illnesses during the FIFA World Cup Qatar 2022.
The primary variables of interest are time-loss injuries and time-loss illnesses.
- Time-loss is defined as inability of a player to complete the current or future training session or match.
- Injury is defined as tissue damage or other derangement of normal physical function resulting from rapid or repetitive transfer of kinetic energy.
- Illness is defined as a health-related complaint or disorder experienced by an athlete, not considered as an injury.
A secondary aim is to analyse injury mechanisms through match video footage of the observed time-loss injuries.
Design Prospective observational cohort study.
This research project will be performed at the FIFA World Cup Qatar 2022, which is played November 20th and December 18th, 2022 in Qatar.
Study duration The study will start from the first day of training with the national team prior the tournament until the day of the last match of the tournament. Consequently, the number of recordings will vary between teams depending on the duration of their pre-tournament training (usually 1-3 weeks), and their performance and progression through the tournament. In order to assess the severity of injuries (based on the length of time a player is unable to play for), all injuries are to be recorded until they are fully rehabilitated, even if this is after the end of the tournament. Each contact person therefore also needs to report when an injured player who has left the tournament has returned to full training with their club team after the tournament.
Demographic information Individual demographic information, including age, height, weight, playing position, and leg dominance (preferred kicking leg), is collected following inclusion.
Injury & illness registration Data on injury and illness is gathered following the recommended methodology in the football extension of the International Olympic Committee consensus statement on methods for recording and reporting of epidemiological data on injury and illness in sport. This includes characteristics such as mode of onset, injury mechanism, diagnosis and classification according to body area, tissue, and pathology type, and illness categories for organ system and etiology. Time-loss will be counted in number of days.
Exposure registration Training and match exposure will be recorded in minutes for each participant for the duration of the tournament. Training exposure includes for example any sports-specific training, strength and conditioning sessions, and active recovery sessions. Illness exposure will be recorded in days for each participant from their first day of training until their last match.
Descriptive statistics is used to provide an overview of the participant demographics and injury and illness occurrence. Injury incidence is calculated as number of injuries per 1000 hours of exposure, and injury burden is calculated as time-loss days per 1000 hours of exposure. Injury incidence and burden will be reported for training and match injuries separately. Illness incidence is calculated per 365 exposure days. Potential missing data will be excluded from analysis and reported accordingly.
Sample size No a priori sample size calculation is performed as we will attempt to include all eligible participants.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Doha, Qatar, 29222
- Aspetar Orthopaedic and Sports Medicine Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- All participating football players at the FIFA World Cup Qatar 2022.
Exclusion Criteria:
- No exclusion criteria are present except declining to provide consent for data to be used in this study.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence and burden of Time-loss injuries
Time Frame: November-December 2022
|
Time-loss is defined as inability of a player to complete the current or future training session or match. Injury is defined as tissue damage or other derangement of normal physical function resulting from rapid or repetitive transfer of kinetic energy. |
November-December 2022
|
Incidence and burden of Time-loss illnesses
Time Frame: November-December 2022
|
Time-loss is defined as inability of a player to complete the current or future training session or match. Illness is defined as a health-related complaint or disorder experienced by an athlete, not considered as an injury. |
November-December 2022
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 003 (NuSkin International)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Injuries
-
Centre Hospitalier Universitaire de NīmesCompletedWounds and Injuries, Hands | Wounds and Injuries, Wrists | Wounds and Injuries, Feet | Wounds and Injuries, AnklesFrance
-
Riverpoint MedicalGlobal CRONot yet recruitingShoulder Injuries | Knee Injuries | Hip Injuries | Ankle Injuries | Foot Injury
-
Stryker EndoscopyRecruitingShoulder Injuries | Knee Injuries | Hip InjuriesUnited States
-
Istanbul UniversityNot yet recruitingKnee Injuries | Hip Injuries | Ankle Injuries | Athletic Injuries | Ankle Sprains | Reinjuries
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedAnterior Cruciate Ligament Injuries | Knee Injuries | Ankle Injuries | Lower Extremity InjuriesUnited States
-
Jia-kuo yuCompletedShoulder Injuries | Knee Injuries | Ankle InjuriesChina
-
Balgrist University HospitalRecruitingSyndesmotic InjuriesSwitzerland
-
St. Clair OrthopaedicsNot yet recruitingSyndesmotic InjuriesUnited States
-
Ataturk UniversityCompletedForearm Injuries | Hand Injuries and DisordersTurkey
-
University of CadizCompleted
Clinical Trials on No intervention implemented. Observational study only
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
University Medicine GreifswaldRecruitingLymphoma | Colorectal Cancer | Pancreas CancerGermany
-
Umeå UniversityCompletedBrain Injuries | Traumatic Intracranial HemorrhageSweden
-
Brian Hiestand MDEmergency Medicine FoundationCompletedHeart Failure, CongestiveUnited States
-
University Medicine GreifswaldRecruitingMalnutrition | Acute PancreatitisGermany
-
University Medicine GreifswaldCompletedGastric Cancer | Pancreatic Cancer | Small Intestine Cancer | Rectal Cancer | Neuroendocrine Tumors | Bile Duct Cancer | Colon Cancer | Liver Cancer | Oesophageal Cancer | GIST, MalignantGermany
-
Elliott Crouser MDCompleted
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Ruijin HospitalHangzhou Genetron Medical Laboratory Co., Ltd.Recruiting
-
Audubon BioscienceEnrolling by invitationCardiovascular Diseases | Autoimmune Diseases | Infectious Disease | Pregnancy Related | Hematologic Malignancy | Oncology | Renal Disease | Gastro-Intestinal Disorder | Genitourinary DiseaseUnited States